Joshua S. Bauchner

Client Alert: Changes Made in New Jersey and New York Employment Law in response to Covid-19

In response to the COVID-19 pandemic, lawmakers in New Jersey and New York have amended the labor and employment laws of their respective states to provide greater protections to employees during this unprecedented time.  A brief summary is provided below:

 

New Jersey

On March 20, 2020, Governor Phil Murphy signed Assembly Bill 3848 (“A3848”) into law, which went into effect immediately.  A3848 prohibits all New Jersey employers for the duration of the Public Health Emergency and State of Emergency (set forth in Executive Order 103 of 2020) from terminating or otherwise penalizing an employee who requests to take or takes time off from work based on the recommendation of a licensed medical professional because the employee has, or is likely to have, an infectious disease.  In addition, an employer may not refuse to reinstate the employee to the position he or she held at the time of taking leave and may not reduce any of the employee’s terms of employment (e.g., seniority, status, benefits, pay, etc.)

A3848 provides that an employee may file a complaint with the Commissioner of the Department of Labor and Workforce Development (“Commissioner”) or initiate a lawsuit in the Superior Court of New Jersey when a violation has occurred.  In the event that the Commissioner or a court finds, by a preponderance of the evidence, that A3848 was violated, the employee must be reinstated to his or her position and the employer will be fined $2,500.

 

New York

On March 18, 2020, Governor Andrew Cuomo signed Senate Bill 8091 (“S8091”), which also went into effect immediately.  S8091 mandates that most New York employers provide paid sick leave to an employee who is subject to a mandatory or precautionary order of quarantine or isolation issued by the state, the New York Department of Health, a local board of health, or any other governmental entity authorized to issue such an order due to COVID-19.  The amount of paid sick leave required depends on the number of employees (as of January 1, 2020), annual revenue, and type of employer as follows:

 

  • All public employers in the State of New York, including municipal governments and school districts: 14 paid sick days.
  • Employees with 100 or more employees: 14 paid sick days.
  • Employers with 11 to 99 employees: 5 paid sick days.
  • Employers with 10 or fewer employees and over $1 million in net income in 2019: 5 paid sick days.
  • Employers with 10 or fewer employees and $1 million or less in net income in 2019: No paid sick days required but employee is entitled to use state paid family leave and disability benefits.

 

When less than fourteen (14) days are provided, S8091 allows the employee to claim state paid family leave and disability benefits upon the exhaustion of his or her allotted number of paid sick leave days.

S8091 also provides that it shall be unlawful for an employer to discharge, threaten, penalize or in any other manner discriminate or retaliate against any employee who uses leave in accordance with the law.

 

Here to Serve You

To best service our clients in response to the COVID-19 pandemic, Ansell Grimm & Aaron, PC created a Task Force comprised of attorneys from various practice areas to digest new legislation and guide our clients through these difficult times.  For additional information, please visit 62q.f7d.myftpupload.com.

 

About Ansell Grimm & Aaron, PC

Ansell Grimm & Aaron, PC was founded in 1929 and has a long history of delivering for clients who come to us to resolve legal matters that are often urgent, stressful, and of great importance. A general practice law firm, Ansell Grimm & Aaron is powered by experienced attorneys who understand that the best outcome is the one that serves the needs of each client.

 

The information provided in this alert was up-to-date at the time of publication, is provided for general purposes only and does not constitute legal advice, and the transmission and receipt of this information does not create or constitute an attorney-client relationship.

Client Alert: What to Expect from the CARES Act – The Paycheck Protection Program

While we are facing a global crisis in connection with the Coronavirus, or COVID-19 pandemic, life as we know it has been significantly disrupted. Small businesses are struggling to stay afloat, especially those that have been made to work remotely, close their doors entirely, or substantially limit their business operations by order of state and local governments.

There may be help on the horizon, however. Congress has passed the $2 trillion dollar Coronavirus Aid, Relief, and Economic Security (CARES) Act in an attempt to minimize the inevitable impact that COVID-19 has and will have on small businesses.

While the Act is very in-depth, there is one section that may be particularly useful to small business owners. The Paycheck Protection Program (“PPP”) has set aside $349 billion for loans that will allow small businesses, which were in operation on February 15, 2020, to retain their employees by covering the cost of payroll amongst other permitted costs.

What costs are permitted under the PPP?
Subject to certain exclusions, costs permitted under the PPP include employee payroll; commissions and cash tips; vacation, parental, family, medical or sick leave; health care premiums; interest on mortgage or other debt obligations; rent under lease agreements; and utilities.

When should I apply?
Loans are only available at this time until June 30, 2020, so prompt application is advisable.

Who do I apply to for a PPP loan?
Loans will be made by lenders who currently provide SBA 7(a) loans, as well as new lenders (both public and private) that the SBA is working quickly to qualify. Forgiveness will also be applied for through the lender.

Who is eligible for a PPP loan?
In order to qualify for a PPP loan, the business (including standard businesses, non-profits, veterans organizations and tribal businesses) has to have fewer than 500 employees, or, according to the SBA, the “applicable size standard in number of employees for the North American Industry Classification System (NAICS) industry as provided by SBA, if higher.” Also, any business that employs 500 or less people per location and has an NAICS code beginning with 72 is eligible. Independent contractors and certain self-employed individuals may qualify for PPP loans, as well.

What are the terms of a PPP loan?
Under the PPP, the maximum loan amount is 250% of the average monthly payroll costs, not to exceed $10,000,000. The goal is to provide businesses with eight weeks’ worth of permissible expenses. For those amounts not otherwise forgiven, the loan term can be up to ten years with an interest rate no higher than 4%. Principal, interest and loan fees will all be deferred for a minimum of six months and a maximum of twelve months. No collateral or personal guaranties may be required in connection with a PPP loan.

What makes a PPP Loan eligible for forgiveness?
PPP Loans are eligible for forgiveness if all employees are retained (or rehired by June 30, 2020). Loan forgiveness will be reduced by the amount that payroll decreases for employees with salaries less than $100,000 per year, if that decrease exceeds 25%. The lender must render and notify the business applicant of a decision within 60 days of the forgiveness application submission.

For more information on the Paycheck Protection Program and to determine your company’s eligibility, please contact us at Ansell Grimm & Aaron, PC at covid19taskforce@62q.f7d.myftpupload.com.

_____________

The information provided in this alert was up-to-date at the time of publication, is provided for general purposes only and does not constitute legal advice, and the transmission and receipt of this information does not create or constitute an attorney-client relationship.

NJ Cannabis Insider reports on recent event, highlighting speakers including Joshua Bauchner

NJ Cannabis Insider reported on its largest panel and networking event, NJ Cannabis Insider Live: The Road to Legalization held on Tuesday, March 10, 2020, at the New Jersey Convention and Expo Center in Edison. The event featured regulators, industry power players, entrepreneurs and professionals.

Among the speakers highlighted were Joshua Bauchner of Ansell, Grimm & Aaron. Other speakers included Jeff Brown, assistant commissioner in charge of the Department of Health’s Medicinal Marijuana Program; Joseph Zoltowski, plant industry director for the state Department of Agriculture; Scott Rudder, president of the New Jersey CannaBusiness Association; Janice Kovach, mayor of Clinton and the first vice president of the New Jersey League of Municipalities; and South Orange Mayor Sheena Collum.

Read the full article on NJCannabisInsider.nj.com  (subscription required)

How a Case Reversed a 100+ Year Precedent and Cleared the Way for Cost-Effective Shore Protections

The impact of the ‘Karan’ decision has and will continue to ripple through New Jersey courts for years to come.

For decades, towns along the coastlines of America have faced a never-ending battle against beach erosion and the damage caused by both major, as well as the cumulative effect of smaller, storms. These storms impact beaches, beachfront, and inland properties and infrastructure. The changes in our climate only will serve to exacerbate these issues. (more…)

New Jersey Launches A Hemp Program In Accord With The Federal Hemp Farming Act Of 2018

New Jersey recently launched a hemp program in accord with the federal Hemp Farming Act of 2018  which removed hemp (generally defined as cannabis with less than 0.3% THC) from Schedule I of the  Controlled Substances Act instead treating it as an ordinary agricultural commodity. Its provisions were incorporated into the 2018 United States Farm bill that became law on December 20, 2018.

New Jersey State Senate President Steve Sweeney spoke at the State Agricultural Convention this month expressing his hopes for the emerging industrial hemp industry in the State, calling hemp the “next major cash crop for New Jersey.”  New Jersey Secretary of Agriculture Doug Fisher also praised this emerging industry: (more…)

Joshua S. Bauchner to Present at the 2nd Annual Cannabis Symposium

Event: 2nd Annual Cannabis Symposium

Date: Wednesday, March 18, 2020

Location: Webcast

Details: Ansell Grimm & Aaron shareholder, Joshua S. Bauchner will present at the 2nd Annual Cannabis Symposium presented by the New Jersey Institute for Continuing Legal Education (NJICLE) in cooperation with the New Jersey State Bar Association (NJSBA) Cannabis Law Special Committee. On Wednesday, March 18, 2020 at 9:10 a.m., Bauchner will join David Vitale, VP, Optimus Partners, LLC in sharing insights on getting legalization on the ballot and into law.

(more…)

Joshua S. Bauchner Presents at NJ Cannabis Insider Conference

Event: NJ Cannabis Insider Live

Date: Tuesday, March 10, 2020

Location: New Jersey Convention and Exposition Center, Edison, NJ

Details: Ansell Grimm & Aaron shareholder, Joshua S. Bauchner will present at NJ Cannabis Insider Live: The Road to Legalization on Tuesday, March 10, 2020 at 1:50 p.m. He will join industry leaders, regulators, and fellow practitioners on a panel titled, “The Ins and Outs of Licensing.”

(more…)

NJ Superior Court Reinforces Stay Against Department of Health Relating to Medical Marijuana Alternative Treatment Center Applications

Court clarifies Dec. 2019 order granting Ansell Grimm & Aaron’s request for a stay of all administrative proceedings relating to all applications for medical marijuana alternative treatment centers.

Ansell Grimm & Aaron’s Cannabis Law attorneys, including practice chair Joshua S. Bauchner and Rahool Patel, represent various companies which applied for medical marijuana licenses with the New Jersey Department of Health (DOH). (more…)